burnout: Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.

Sponsor
Hamad Medical Corporation (Industry)
Overall Status
Completed
CT.gov ID
NCT04620005
Collaborator
(none)
1,000
1
12
83.6

Study Details

Study Description

Brief Summary

The burnout phenomenon first came to clinical science 50 years ago. It is exponentially rising worldwide which prompted its discoverers to develop the most popular tool for its assessment, known as the Maslach burnout inventory (MBI)1. Common symptoms of burnout include depression, irritability, and insomnia. The growing demand for extra-corporeal membrane oxygenation (ECMO) may have an effect on burnout as the newly introduced services is demanding in effort and put the practitioners on complex ethical and administrative situations.

We conducted a cross-sectional descriptive study using a combined methodological quantitative and qualitative approach involving a convenience sample of 1000 healthcare practitioners within surgical and medical ICUs of Hamad Medical Corporation (HMC), Qatar. We will use used two main instruments to develop an online questionnaire: - The MBI-human service survey (MBI-HSS) and the Leadership scale Expectations: we expect that we will have a new insight about the impact of these complex interventions on practitioner's burnout.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational

Detailed Description

This study predominates at investigating the BOS in ECMO ICU and non-ECMO ICU, and whether the leadership attitude could have effect on the mentioned syndrome problem.

Methodology Settings This study will in a tertiary hospital in the Middle East "Hamad Medical Corporation" as a main centre, the study will be disseminated an online survey among other centres who will agree to participate on. The participants will be screened for socio-demographic data such as age, gender, profession, marital state, education, native country, years of experience, weekly working hours and salary. The questionnaire was clarified to the potential respondents in order to clear any poor understanding. English used as the official language in the organization; translation of the used instruments to individual mother languages is not required.

Design Cross-sectional descriptive survey with purposeful sampling. Mixed qualitative and quantitative methodology used in this dissertation. Invitations to participate through the mail, anonymous questionnaire survey will be presented to the staff members including physicians, nurses and respiratory therapists who work as full time.

  1. Study Population and Study Setting/ Location In this section describe the study population that is to be enrolled in the study, planned recruitment number and Inclusion and Exclusion Criteria to be listed here. Also list the Hospitals in which this study will be conducted ( e.g. HGH, Rumailah etc) The study population would include physicians, nurses, and respiratory therapists working in ICUs. The inclusion criteria will include practitioners working in intensive care unit including physician, respiratory therapists and nurses who agree to participate in the survey. We will exclude practitioners who decline to participate and who will not complete the questionnaires. A flow diagram will be prepared for the enrollment.

The participants will be approached through communication with one representative within the assigned ICUs within Qatar, in case of agreement we will ask for a list of mails from each department to be enrolled in the study.

  1. Study procedures

The study will be conducted for 12 months from the time of ethical approval. Instrumentation

The used instrumentation is questionnaire that is divided into the following sections:
  1. Condition of work effectiveness questionnaire (CWEQ): This scale consisted of 19 items developed by Kanter, (1977) measured by a 5-point Likert type response. (9) B) Maslach Burnout Inventory human services survey (MBI-HSS): The scale is a standardized instrument to measure burnout it utilize 9 items related to emotional exhaustion and it is most frequently used in health care researches, the nine items are calculated to get the whole score, scores of 27 and more signals severe burnout. (10) The percentage of high degree of burnout was used for advanced analysis. We will get permission to use this scale from (Mindgarden.com, USA) C) Leadership Behaviours scale (LS): The staff discernment of managers' leadership attitude will be measured using the 11 item Manager Action Scale. (11)

The questionnaires will be submitted in English form; no need for translation, as health care practitioners in the organization, must practice English that is the official language at workplace. The results of the analysis will be presented using descriptive methods. The quantitative and qualitative data will be analysed statistically, the relations between the variables will be interpreted, the relation between burnout score and socio-demographic variables, occupational stress score, and empowerment scale will be assessed statistically using (t-test, analysis of variance, correlation efficient and regression).

Ethical Considerations:

Participant identity kept confidential, final report would not contain any identity. Comprehensive explanation for the participants about the questionnaires, the type, purpose of the study and outcome was done, early rejection, or late withdrawal was permissive. Ethical approval was obtained according to the corporate regulations. The ethical consent attached after being approval from the medical research centre.

Health care practitioners working on ICU whether providing ECMO services or not will be eligible to participate in the study

The primary objective will be to detect the prevalence of burnout among health care practitioner s working in ICU with ECMO services The secondary objectives will be to compare the burnout association in ECMO and non ECMO ICU, the effect of leadership attitude on burnout syndrome and to look at the burnout in special population within the groups like respiratory therapists

Study Design

Study Type:
Observational
Actual Enrollment :
1000 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
ECMO

The first group will include practitioners who work in intensive care unit with ECMO services

Other: Observational
Survey

Non-ECMO

The second group will include practitioners who work in non-ECMO inventive care unit

Other: Observational
Survey

Outcome Measures

Primary Outcome Measures

  1. Questionnaire assessing prevalence of burnout among health care practitioners working in ICU with ECMO services [1 year]

Secondary Outcome Measures

  1. The difference in burnout association in practitioners in ICU with ECMO services and in conventional ICU [1 year]

  2. effect of leadership attitude on burnout syndrome [1 year]

    Through specific questionnaire

  3. burnout in special population within the respiratory therapists [1 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The inclusion criteria will include practitioners working in intensive care unit including physician, respiratory therapists and nurses who agree to participate in the survey
Exclusion Criteria:
  • practitioners who decline to participate and who will not complete the questionnaires.

  • Non ICU practitioners

  • Perfusionists

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hamad medical corporation Doha DA Qatar 3050

Sponsors and Collaborators

  • Hamad Medical Corporation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamad Medical Corporation
ClinicalTrials.gov Identifier:
NCT04620005
Other Study ID Numbers:
  • MRC-01-20-113
First Posted:
Nov 6, 2020
Last Update Posted:
Dec 3, 2021
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hamad Medical Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 3, 2021